A Follow-up of a Phase 3 Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel in the Treatment of Complex Perianal Fistula in Subjects With Crohn's Disease Who Have Participated in ADMIRE II Study
Latest Information Update: 28 Apr 2025
At a glance
- Drugs Darvadstrocel (Primary)
- Indications Rectal fistula
- Focus Adverse reactions; Registrational
- Sponsors Takeda Oncology
Most Recent Events
- 03 May 2024 Status changed from active, no longer recruiting to completed.
- 25 Apr 2024 This trial has been completed in Poland (Global end date: 2 Apr 2024).
- 19 Apr 2024 This trial has been completed in France and Hungary, according to European Clinical Trials Database record .